Morphine/Naltrexone Combo Withdrawn

King Pharmaceuticals notes that Embeda, a combination of morphine and naltrexone, has been voluntarily withdrawn because "a prespecified stability requirement was not met during routine testing."
Medscape Medical News

Full Story →